Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Christina Aquilante

Concepts (344)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacogenetics
27
2022
149
5.890
Why?
Pharmacogenomic Testing
13
2022
54
4.640
Why?
Thiazolidinediones
8
2016
146
2.940
Why?
Aryl Hydrocarbon Hydroxylases
10
2014
43
2.610
Why?
Heart Transplantation
8
2021
672
2.390
Why?
Polymorphism, Genetic
17
2019
641
2.310
Why?
Precision Medicine
9
2024
354
1.710
Why?
Polymorphism, Single Nucleotide
10
2021
2057
1.560
Why?
Hypoglycemic Agents
11
2020
1031
1.560
Why?
Health Personnel
4
2021
578
1.540
Why?
Transplant Recipients
5
2021
148
1.350
Why?
Blood Pressure
8
2020
1656
1.230
Why?
Organ Transplantation
2
2020
164
1.220
Why?
Cytochrome P-450 CYP2D6
4
2022
25
1.140
Why?
Metabolic Syndrome
4
2016
392
1.130
Why?
Graft Rejection
2
2021
548
1.060
Why?
Pharmacists
3
2022
235
1.030
Why?
Cytochrome P-450 CYP3A
6
2016
60
0.850
Why?
Gemfibrozil
2
2013
10
0.840
Why?
Sulfonylurea Compounds
3
2018
44
0.810
Why?
Leukopenia
1
2021
26
0.810
Why?
Adiponectin
2
2016
224
0.810
Why?
Hepatocyte Nuclear Factor 1-alpha
1
2021
16
0.810
Why?
Hypolipidemic Agents
2
2013
86
0.790
Why?
Mycophenolic Acid
1
2021
79
0.780
Why?
Desogestrel
5
2021
41
0.760
Why?
Organic Anion Transporters
2
2011
19
0.750
Why?
Biological Specimen Banks
2
2024
103
0.740
Why?
Genotype
16
2021
1870
0.740
Why?
Hypertension
3
2020
1199
0.710
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2013
387
0.700
Why?
Adult
41
2022
31324
0.700
Why?
Middle Aged
38
2021
27510
0.680
Why?
Prescription Drugs
2
2020
113
0.670
Why?
Cytochrome P-450 CYP2C8
7
2014
15
0.670
Why?
Cardiologists
1
2018
40
0.660
Why?
Humans
73
2024
118251
0.640
Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2021
44
0.630
Why?
Physicians
3
2021
792
0.620
Why?
HIV Protease Inhibitors
4
2016
64
0.610
Why?
Female
50
2021
61261
0.600
Why?
Decision Support Systems, Clinical
1
2020
176
0.600
Why?
Male
46
2021
57474
0.600
Why?
Academic Medical Centers
1
2020
422
0.590
Why?
Ritonavir
4
2012
70
0.590
Why?
Heart Failure
4
2017
1967
0.570
Why?
Polypharmacy
1
2017
75
0.560
Why?
Warfarin
3
2008
139
0.560
Why?
Lectins
1
2016
49
0.550
Why?
Attitude of Health Personnel
2
2020
990
0.550
Why?
Cytochrome P-450 CYP2C19
5
2022
21
0.540
Why?
Nonprescription Drugs
1
2016
67
0.540
Why?
Antiviral Agents
1
2021
653
0.530
Why?
Tacrolimus
1
2016
149
0.530
Why?
Medicare
1
2020
664
0.510
Why?
Cytochrome P-450 Enzyme System
2
2006
111
0.510
Why?
Contraceptive Agents, Female
3
2020
65
0.500
Why?
Death, Sudden, Cardiac
3
2021
166
0.490
Why?
Pediatrics
2
2021
980
0.480
Why?
Blood Pressure Determination
1
2014
133
0.460
Why?
Arrhythmias, Cardiac
3
2021
277
0.460
Why?
Chemokine CXCL5
3
2012
11
0.450
Why?
Heptanoic Acids
1
2013
62
0.440
Why?
Pyrazines
1
2013
72
0.430
Why?
Diabetes Mellitus, Type 2
5
2020
2159
0.420
Why?
Resistin
2
2010
13
0.420
Why?
Pravastatin
1
2011
29
0.420
Why?
Pyrroles
1
2013
188
0.410
Why?
Pharmaceutical Preparations
3
2009
168
0.410
Why?
Triazoles
1
2013
128
0.410
Why?
Cross-Sectional Studies
8
2020
4521
0.410
Why?
Health Knowledge, Attitudes, Practice
4
2021
1183
0.400
Why?
Dobutamine
3
2008
36
0.400
Why?
Retrospective Studies
12
2021
12929
0.380
Why?
Managed Care Programs
2
2022
135
0.370
Why?
Antidepressive Agents
2
2022
189
0.370
Why?
Aged
17
2021
19594
0.360
Why?
Mixed Function Oxygenases
2
2008
37
0.350
Why?
Drug Interactions
5
2017
351
0.350
Why?
DNA
1
2016
1385
0.350
Why?
Chromatography, Liquid
1
2010
353
0.340
Why?
Young Adult
13
2021
10731
0.330
Why?
Polymerase Chain Reaction
3
2006
1004
0.330
Why?
Sulfonamides
1
2011
444
0.320
Why?
Drug Prescriptions
4
2021
248
0.320
Why?
Health
1
2008
80
0.320
Why?
Cytokines
1
2016
1880
0.320
Why?
Chemokine CCL2
1
2008
124
0.310
Why?
Blood Glucose
3
2016
1936
0.310
Why?
Time Factors
8
2020
6368
0.310
Why?
Drug Implants
4
2021
72
0.310
Why?
Mass Spectrometry
1
2010
670
0.300
Why?
Immunosuppressive Agents
4
2021
682
0.300
Why?
Heart Rate
3
2008
729
0.300
Why?
Receptors, Adrenergic, beta
1
2008
142
0.300
Why?
Matrix Metalloproteinase 8
1
2006
8
0.300
Why?
Haplotypes
5
2013
474
0.290
Why?
Sequence Analysis, DNA
4
2012
748
0.290
Why?
Vitamin K Epoxide Reductases
3
2020
12
0.280
Why?
Metoprolol
1
2006
37
0.280
Why?
Blood Coagulation Factors
1
2006
42
0.270
Why?
Clinical Laboratory Techniques
1
2006
89
0.270
Why?
Autonomic Nervous System
1
2006
66
0.270
Why?
Clinical Protocols
2
2017
234
0.260
Why?
Administration, Oral
4
2016
753
0.260
Why?
Models, Biological
1
2013
1701
0.260
Why?
Echocardiography
1
2008
556
0.260
Why?
Cross-Over Studies
3
2013
456
0.260
Why?
Anticoagulants
2
2008
555
0.260
Why?
Prospective Studies
6
2020
6443
0.260
Why?
Genetic Variation
3
2019
912
0.250
Why?
Echocardiography, Stress
1
2004
21
0.250
Why?
Polymorphism, Restriction Fragment Length
1
2004
64
0.250
Why?
Adrenergic beta-Antagonists
1
2006
301
0.240
Why?
Carrier Proteins
1
2008
725
0.240
Why?
Cohort Studies
7
2021
5078
0.240
Why?
Biotransformation
2
2013
52
0.230
Why?
Cytochrome P-450 CYP2C9
4
2019
18
0.230
Why?
Metformin
1
2007
293
0.230
Why?
Alleles
6
2012
829
0.230
Why?
Waist Circumference
2
2016
130
0.220
Why?
Gene Frequency
4
2013
511
0.210
Why?
Follow-Up Studies
4
2021
4574
0.210
Why?
Antimalarials
2
2013
24
0.210
Why?
Clinical Trials as Topic
1
2006
964
0.210
Why?
Drug Dosage Calculations
1
2020
21
0.190
Why?
Calcineurin Inhibitors
1
2021
60
0.190
Why?
Pharmacogenomic Variants
2
2021
35
0.190
Why?
Antibiotics, Antineoplastic
1
2021
114
0.190
Why?
Egypt
1
2020
10
0.190
Why?
Cytomegalovirus
1
2021
144
0.190
Why?
Atazanavir Sulfate
3
2016
41
0.190
Why?
Area Under Curve
2
2013
293
0.180
Why?
Aged, 80 and over
4
2017
6541
0.180
Why?
No-Show Patients
1
2019
1
0.180
Why?
Menstruation Disturbances
1
2019
12
0.180
Why?
Hemodynamics
1
2004
1002
0.180
Why?
Colorado
3
2024
4178
0.180
Why?
Blood Pressure Monitoring, Ambulatory
1
2020
66
0.180
Why?
Lipids
2
2016
591
0.180
Why?
Cytochrome P450 Family 3
1
2019
2
0.180
Why?
Brain Chemistry
1
2000
118
0.170
Why?
United States
8
2021
12488
0.170
Why?
Smoking
1
2006
1478
0.170
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2013
301
0.170
Why?
Oligopeptides
2
2012
250
0.170
Why?
Double-Blind Method
2
2016
1683
0.170
Why?
Morphine
1
2000
132
0.170
Why?
Body Weight
2
2016
923
0.170
Why?
Patients
1
2020
174
0.160
Why?
Sitagliptin Phosphate
2
2021
30
0.160
Why?
Child Health Services
1
2020
177
0.160
Why?
Body Mass Index
3
2019
2074
0.160
Why?
Bariatric Surgery
1
2021
166
0.160
Why?
Progesterone
1
2019
242
0.160
Why?
Ventricular Dysfunction
1
2018
15
0.160
Why?
Dose-Response Relationship, Drug
3
2016
1937
0.160
Why?
Apyrase
1
2017
13
0.150
Why?
Pyridines
2
2012
436
0.150
Why?
Healthy Volunteers
2
2019
194
0.150
Why?
Organophosphonates
2
2008
94
0.150
Why?
Depression
2
2022
1133
0.150
Why?
Anti-HIV Agents
2
2016
662
0.140
Why?
Psychiatry
1
2020
200
0.140
Why?
DNA Primers
3
2006
532
0.140
Why?
Circadian Rhythm
1
2020
394
0.140
Why?
Pyrophosphatases
1
2016
22
0.140
Why?
Chronic Disease
2
2017
1630
0.140
Why?
Treatment Outcome
6
2021
9319
0.140
Why?
GPI-Linked Proteins
1
2016
56
0.140
Why?
Electronic Health Records
2
2020
809
0.140
Why?
Cardiology
1
2018
272
0.140
Why?
Patient Care
1
2016
105
0.140
Why?
Adenine
2
2008
222
0.140
Why?
Gene Expression Regulation, Enzymologic
1
2017
287
0.130
Why?
Ribavirin
1
2016
88
0.130
Why?
Students, Pharmacy
1
2016
99
0.130
Why?
HIV Infections
4
2016
2454
0.130
Why?
Metabolic Clearance Rate
2
2013
111
0.130
Why?
Therapeutics
1
2015
12
0.130
Why?
Education, Pharmacy
1
2016
130
0.130
Why?
beta-Cyclodextrins
1
2015
31
0.130
Why?
Delivery of Health Care
1
2022
862
0.130
Why?
Voriconazole
1
2015
24
0.130
Why?
Renal Replacement Therapy
1
2015
70
0.130
Why?
Surgical Procedures, Operative
1
2017
214
0.130
Why?
Patient Education as Topic
1
2019
696
0.120
Why?
Antigens, CD
1
2017
457
0.120
Why?
Diltiazem
1
2014
22
0.120
Why?
Adolescent
6
2021
18364
0.120
Why?
Antifungal Agents
1
2015
134
0.120
Why?
Chromosomes, Human, Pair 10
1
2013
19
0.120
Why?
Reoperation
1
2016
557
0.120
Why?
Cardiomyopathies
1
2017
298
0.120
Why?
Venous Thromboembolism
1
2017
233
0.120
Why?
Kidney Transplantation
1
2019
576
0.110
Why?
Half-Life
1
2013
147
0.110
Why?
Sirolimus
1
2014
195
0.110
Why?
Medication Adherence
1
2017
554
0.110
Why?
Liver Transplantation
1
2019
843
0.110
Why?
Practice Patterns, Physicians'
1
2020
1197
0.100
Why?
Tissue Distribution
2
2014
332
0.100
Why?
Darunavir
1
2011
17
0.100
Why?
Lung Transplantation
1
2014
263
0.100
Why?
Self Care
1
2014
356
0.100
Why?
Genetic Association Studies
1
2013
355
0.100
Why?
Prevalence
1
2017
2321
0.100
Why?
Acquired Immunodeficiency Syndrome
1
2012
219
0.090
Why?
Reverse Transcriptase Inhibitors
2
2008
80
0.090
Why?
Insulin Resistance
2
2010
1167
0.090
Why?
Patient Discharge
1
2016
791
0.090
Why?
Cholesterol
1
2011
375
0.090
Why?
Phenotype
2
2016
2937
0.090
Why?
Longitudinal Studies
1
2016
2491
0.090
Why?
Triglycerides
1
2011
515
0.090
Why?
Leukocytes
2
2012
284
0.090
Why?
ATP-Binding Cassette Transporters
1
2010
125
0.090
Why?
Kidney Failure, Chronic
1
2015
514
0.090
Why?
Lipoproteins
1
2010
163
0.090
Why?
Surveys and Questionnaires
1
2020
4684
0.080
Why?
Risk Assessment
3
2020
3043
0.080
Why?
Databases, Factual
3
2021
1196
0.080
Why?
Lung Diseases
1
2014
709
0.080
Why?
Incidence
2
2020
2413
0.080
Why?
Weight Gain
2
2021
485
0.070
Why?
Drug Delivery Systems
1
2010
306
0.070
Why?
Pyrimidinones
1
2007
86
0.070
Why?
Indinavir
1
2006
6
0.070
Why?
Cardiovascular Diseases
2
2010
1795
0.070
Why?
Reproducibility of Results
1
2014
2855
0.070
Why?
Biomarkers
3
2014
3567
0.070
Why?
Genetic Techniques
1
2006
60
0.070
Why?
Cost-Benefit Analysis
2
2012
551
0.070
Why?
Linear Models
2
2019
817
0.070
Why?
Lamivudine
1
2006
59
0.070
Why?
Oxidation-Reduction
1
2009
935
0.070
Why?
Factor X
1
2006
25
0.070
Why?
Prothrombin
1
2006
21
0.070
Why?
Zidovudine
1
2006
77
0.070
Why?
Factor VII
1
2006
22
0.070
Why?
International Normalized Ratio
1
2006
42
0.070
Why?
Chemokines, CXC
1
2006
61
0.070
Why?
Drug Utilization
1
2007
169
0.070
Why?
Prognosis
2
2014
3424
0.070
Why?
C-Reactive Protein
1
2008
364
0.070
Why?
Base Sequence
2
2006
2148
0.070
Why?
Delayed-Action Preparations
1
2006
161
0.070
Why?
Regression Analysis
1
2008
984
0.070
Why?
Health Care Surveys
1
2007
544
0.060
Why?
Mathematical Computing
1
2004
13
0.060
Why?
Gene Expression Regulation
1
2014
2435
0.060
Why?
Risk Factors
3
2020
8958
0.060
Why?
Gene Expression
1
2009
1482
0.060
Why?
Drug Labeling
1
2004
44
0.060
Why?
Infusions, Intravenous
1
2004
379
0.060
Why?
Laboratories
1
2004
96
0.060
Why?
Multidrug Resistance-Associated Proteins
3
2008
36
0.060
Why?
Kidney
2
2008
1351
0.060
Why?
Reference Values
1
2004
770
0.060
Why?
Socioeconomic Factors
1
2007
1121
0.050
Why?
Linagliptin
1
2021
4
0.050
Why?
Adamantane
1
2021
16
0.050
Why?
Administrative Claims, Healthcare
1
2021
22
0.050
Why?
Dipeptides
1
2021
51
0.050
Why?
Electronic Prescribing
1
2021
4
0.050
Why?
Electrocardiography
1
2004
555
0.050
Why?
Uterine Hemorrhage
1
2021
36
0.050
Why?
Protective Factors
1
2020
90
0.040
Why?
Drug Tolerance
1
2000
78
0.040
Why?
Animals
3
2008
33152
0.040
Why?
Costs and Cost Analysis
1
2020
201
0.040
Why?
Treatment Failure
1
2020
340
0.040
Why?
Homozygote
2
2012
189
0.040
Why?
Kaplan-Meier Estimate
1
2021
840
0.040
Why?
Genomics
1
2024
668
0.040
Why?
Genetic Testing
1
2021
388
0.040
Why?
Attitude
1
2020
230
0.040
Why?
Diabetes Mellitus
1
2006
939
0.040
Why?
Glipizide
1
2018
6
0.040
Why?
Feasibility Studies
1
2021
746
0.040
Why?
Antineoplastic Agents
1
2009
1967
0.040
Why?
Proportional Hazards Models
1
2021
1124
0.040
Why?
Organic Anion Transport Protein 1
2
2008
6
0.040
Why?
Glyburide
1
2018
36
0.040
Why?
Liver
1
2006
1803
0.040
Why?
Social Class
1
2019
217
0.040
Why?
Dexamethasone
1
2000
319
0.040
Why?
Self-Management
1
2019
133
0.040
Why?
Self Report
1
2021
698
0.040
Why?
Anesthetics
1
2017
58
0.040
Why?
Membrane Transport Proteins
2
2008
136
0.040
Why?
Tenofovir
2
2008
200
0.040
Why?
Peru
1
2016
59
0.030
Why?
Perioperative Care
1
2017
131
0.030
Why?
Pharmaceutical Services
1
2016
79
0.030
Why?
Medicaid
1
2020
411
0.030
Why?
Cause of Death
1
2018
379
0.030
Why?
Diabetic Angiopathies
1
2018
261
0.030
Why?
South Africa
1
2016
163
0.030
Why?
Alternative Splicing
1
2017
190
0.030
Why?
Indians, North American
1
2021
598
0.030
Why?
Preoperative Care
1
2017
332
0.030
Why?
HEK293 Cells
1
2017
625
0.030
Why?
Rats, Sprague-Dawley
1
2000
2434
0.030
Why?
Hepatitis C, Chronic
1
2016
151
0.030
Why?
Everolimus
1
2014
64
0.030
Why?
Receptors, Steroid
1
2014
54
0.030
Why?
Demography
1
2014
273
0.030
Why?
Hypoglycemia
1
2018
401
0.030
Why?
Age Factors
1
2019
2990
0.030
Why?
Mental Disorders
1
2020
935
0.030
Why?
Vasodilator Agents
1
2014
328
0.030
Why?
Heterozygote
1
2012
260
0.030
Why?
Rats
1
2000
5339
0.020
Why?
Genetic Loci
1
2012
281
0.020
Why?
Insulin
1
2019
2157
0.020
Why?
Critical Illness
1
2015
661
0.020
Why?
Algorithms
2
2008
1522
0.020
Why?
Multivariate Analysis
1
2012
1469
0.020
Why?
Body Composition
1
2012
644
0.020
Why?
Genetic Predisposition to Disease
1
2017
2262
0.020
Why?
Plasma
1
2009
194
0.020
Why?
Lopinavir
1
2007
29
0.020
Why?
PubMed
1
2006
11
0.020
Why?
Ribosomal Proteins
1
2006
68
0.020
Why?
Antiretroviral Therapy, Highly Active
1
2007
258
0.020
Why?
Pharmacology
1
2005
8
0.020
Why?
RNA, Messenger
1
2012
2657
0.020
Why?
Likelihood Functions
1
2005
136
0.020
Why?
Molecular Sequence Data
1
2009
2855
0.020
Why?
Mitochondrial Proteins
1
2006
224
0.020
Why?
Cardiotonic Agents
1
2005
127
0.020
Why?
Hemorrhage
1
2008
606
0.010
Why?
Genome
1
2006
271
0.010
Why?
Chromosome Mapping
1
2005
508
0.010
Why?
Drug Therapy, Combination
1
2006
964
0.010
Why?
Predictive Value of Tests
1
2008
1857
0.010
Why?
Saccharomyces cerevisiae Proteins
1
2006
347
0.010
Why?
Models, Genetic
1
2005
592
0.010
Why?
Pilot Projects
1
2006
1405
0.010
Why?
Child
1
2020
19033
0.010
Why?
Computer Simulation
1
2005
913
0.010
Why?
Case-Control Studies
1
2007
3156
0.010
Why?
Inflammation
1
2006
2545
0.010
Why?
Aquilante's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)